Implantica AG (IPLTF)

Implantica AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,465	880	673	1,080	2,035	5,273
Market Cap Growth	53.81%	30.85%	-37.68%	-46.95%	-61.41%	-
Enterprise Value	1,396	808	564	955	1,882	5,157
PS Ratio	629.05	439.19	432.27	1199.73	4624.09	28361.40
PB Ratio	14.02	8.49	4.87	7.01	11.21	37.52
P/TBV Ratio	21.85	8.28	4.79	6.94	11.14	37.53
EV/Sales Ratio	-	402.89	362.30	1061.14	4277.09	27737.98
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.60	-0.64	-0.70	-0.75	-0.83	-0.85
Net Debt / EBITDA Ratio	2.62	2.52	4.00	5.86	10.13	9.18
Net Debt / FCF Ratio	3.18	2.81	4.35	6.73	11.40	9.36
Asset Turnover	0.02	0.02	0.01	0.01	0.00	0.00
Inventory Turnover	13.22	11.37	5.52	8.34	7.86	5.60
Quick Ratio	23.86	19.94	23.68	33.76	41.35	63.44
Current Ratio	23.98	20.33	23.93	34.02	41.49	63.69
Return on Equity (ROE)	-20.39%	-21.04%	-18.21%	-14.06%	-11.27%	-16.26%
Return on Assets (ROA)	-12.52%	-13.60%	-9.81%	-7.40%	-5.87%	-9.76%
Return on Capital Employed (ROCE)	-22.70%	-25.30%	-17.30%	-12.70%	-8.20%	-9.20%
Earnings Yield	-1.58%	-2.74%	-3.90%	-2.06%	-0.86%	-0.24%
FCF Yield	-1.34%	-2.68%	-3.28%	-1.59%	-0.65%	-0.24%
Buyback Yield / Dilution	-0.03%	-0.01%	0.01%	-0.56%	-6.82%	-485.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.